Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Humeral Tuberosity Fractures: Presentation, Management, and Early Outcomes.

Journal of the Pediatric Orthopaedic Society of North America·2026
Same author

Epidemiology of early-onset and late-onset invasive infections in Australian neonates and infants: a retrospective multicentre study.

BMJ public health·2025
Same author

Nerve Recovery in Pediatric Supracondylar Humeral Fractures: Assessing the Impact of Time to Surgery.

The Journal of bone and joint surgery. American volume·2025
Same author

Risk Model-Guided Clinical Decision Support for Suicide Screening: A Randomized Clinical Trial.

JAMA network open·2025
Same author

Systemic complications of Aicardi Goutières syndrome using real-world data.

Molecular genetics and metabolism·2024
Same author

Diagnostic Criteria for Primary Tic Disorders: Time for Reappraisal.

Movement disorders : official journal of the Movement Disorder Society·2024
Same journal

Breathing Physiology into the Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

The Science and Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

Ex Utero Artificial Womb Support: Promising Future for Extremely Preterm Infants.

Clinics in perinatology·2026
Same journal

Advances in the Use of Cell-Based Therapies for Prevention of Bronchopulmonary Dysplasia.

Clinics in perinatology·2026
Same journal

Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant.

Clinics in perinatology·2026
Same journal

Modern Surfactant Delivery Methods with a Focus on Implementation of Surfactant Administration Through Laryngeal and Supraglottic Airways.

Clinics in perinatology·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Adjunctive immunologic interventions in neonatal sepsis.

William Tarnow-Mordi1, David Isaacs, Sourabh Dutta

  • 1Westmead International Network for Neonatal Education and Research (WINNER) Institute, Centre for Newborn Care, Westmead Hospital, University of Sydney, Hawkesbury Road, New South Wales 2145, Australia. williamtm@med.usyd.edu.au <williamtm@med.usyd.edu.au>

Clinics in Perinatology
|June 24, 2010
PubMed
Summary
This summary is machine-generated.

Limited randomized controlled trials hinder evaluation of immunologic interventions for neonatal sepsis. International collaboration is crucial for reliable data on mortality and disability-free survival, with promising prophylactic options identified.

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Related Experiment Videos

Last Updated: Jun 12, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Area of Science:

  • Neonatal immunology
  • Clinical trials
  • Infectious disease prevention

Background:

  • Randomized controlled trials (RCTs) for neonatal sepsis interventions often lack adequate sample sizes.
  • Reliable evaluation of immunologic treatments for neonatal sepsis is therefore limited.
  • International collaboration is essential to gather sufficient data.

Purpose of the Study:

  • To review promising immunologic interventions for treating and preventing neonatal sepsis.
  • To highlight the need for larger sample sizes and international cooperation in research.
  • To identify interventions with potential efficacy based on available evidence.

Main Methods:

  • Review of existing literature on immunologic interventions for neonatal sepsis.
  • Analysis of potential therapeutic and prophylactic strategies.
  • Assessment of evidence regarding effects on mortality and disability-free survival.

Main Results:

  • Prophylactic oral probiotics show significant efficacy (P<.00001) in reducing all-cause mortality and necrotizing enterocolitis in preterm infants by over 50%.
  • However, prophylactic oral probiotics do not reduce sepsis rates.
  • Promising therapeutic interventions include exchange transfusions, pentoxifylline, and IgM-enriched intravenous immunoglobulin.
  • Promising prophylactic interventions include lactoferrin (with or without probiotics), selenium, early antibiotic cessation, breast milk, and early colostrum initiation.

Conclusions:

  • International collaboration is vital for conducting robust RCTs in neonatal sepsis.
  • Several immunologic interventions show promise for prevention and treatment, particularly prophylactic oral probiotics for mortality and necrotizing enterocolitis in preterm infants.
  • Further research with adequate sample sizes is needed to confirm the efficacy of these interventions.